메뉴 건너뛰기




Volumn 38, Issue 1, 2009, Pages 62-67

Can computer simulations replace clinical pharmacokinetic studies? The In-silico-Child;Können computer-simulationen klinisch-pharmakokinetische studien ersetzen? Das In-silico-Child

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SAMPLING; CHILD; CLINICAL STUDY; COMPUTER MODEL; COMPUTER SIMULATION; DOSE CALCULATION; DRUG INDUSTRY; HUMAN; INTENSIVE CARE UNIT; METHODOLOGY; PEDIATRICS; PHARMACOKINETICS; SHORT SURVEY; METABOLISM; REVIEW;

EID: 59349092572     PISSN: 00483664     EISSN: 16151003     Source Type: Journal    
DOI: 10.1002/pauz.200800297     Document Type: Short Survey
Times cited : (6)

References (10)
  • 1
    • 24044436574 scopus 로고    scopus 로고
    • A literature review on off-label drug use in children
    • Pandolfini, C., Bonati, M.: A literature review on off-label drug use in children. Eur. J. Pediatr. 164 (2005), 552-558.
    • (2005) Eur. J. Pediatr , vol.164 , pp. 552-558
    • Pandolfini, C.1    Bonati, M.2
  • 2
    • 33747495601 scopus 로고    scopus 로고
    • Off-label and unlicensed prescribing for newborns and children in different settings: A review of the literature and a consideration about drug safety
    • Cuzzolin, L., Atzei, A., Fanos, V.: Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin. Drug Saf. 5 (2006), 703-718.
    • (2006) Expert Opin. Drug Saf , vol.5 , pp. 703-718
    • Cuzzolin, L.1    Atzei, A.2    Fanos, V.3
  • 3
    • 84868890084 scopus 로고    scopus 로고
    • Pub L
    • FDA: Best Pharmaceuticals for Children Act. Pub L No. 107-109 (2002) (http://www.fda.gov/opacom/laws/pharmkids/contents.html).
    • (2002) Best Pharmaceuticals for Children Act , Issue.107-109
  • 4
  • 6
    • 34447330544 scopus 로고    scopus 로고
    • Whole-body physiologically based pharmacokinetic models
    • Nestorov, I.: Whole-body physiologically based pharmacokinetic models. Expert Opin. Drug Metab. Toxicol. 3 (2007), 235-249.
    • (2007) Expert Opin. Drug Metab. Toxicol , vol.3 , pp. 235-249
    • Nestorov, I.1
  • 7
    • 52649130373 scopus 로고    scopus 로고
    • Whole body physiologically-based pharmacokinetic models: Their use in clinical drug development
    • Edginton, A.N., Theil, F.-P., Schmitt, W., Willmann, S.: Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin. Drug Metab. Toxicol. 4 (2008), 1143-1152.
    • (2008) Expert Opin. Drug Metab. Toxicol , vol.4 , pp. 1143-1152
    • Edginton, A.N.1    Theil, F.-P.2    Schmitt, W.3    Willmann, S.4
  • 9
    • 33745584148 scopus 로고    scopus 로고
    • Development and evaluation of a generic physiologically based pharmacokinetic model for children
    • Edginton, A.N., Schmitt, W., Willmann, S.: Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin. Pharmacokinet. 45 (2006), 1013-1034.
    • (2006) Clin. Pharmacokinet , vol.45 , pp. 1013-1034
    • Edginton, A.N.1    Schmitt, W.2    Willmann, S.3
  • 10
    • 33745599327 scopus 로고    scopus 로고
    • A mechanistic approach for the scaling of clearance in children
    • Edginton, A.N., Schmitt, W., Voith, B., Willmann, S.: A mechanistic approach for the scaling of clearance in children. Clin. Pharmacokinet. 45 (2006), 683-704.
    • (2006) Clin. Pharmacokinet , vol.45 , pp. 683-704
    • Edginton, A.N.1    Schmitt, W.2    Voith, B.3    Willmann, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.